©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Jul 27, 2015; 7(7): 102-106
Published online Jul 27, 2015. doi: 10.4240/wjgs.v7.i7.102
Published online Jul 27, 2015. doi: 10.4240/wjgs.v7.i7.102
Perspective of laparoscopic liver resection for hepatocellular carcinoma
Zenichi Morise, Department of Surgery, Fujita Health University School of Medicine, Banbuntane Houtokukai Hospital, Nagoya, Aichi 454-8509, Japan
Author contributions: Morise Z solely contributed to this paper.
Conflict-of-interest statement: The author has no conflict of interest to declare.
Correspondence to: Zenichi Morise, MD, PhD, FACS, Department of Surgery, Fujita Health University School of Medicine, Banbuntane Houtokukai Hospital, 3-6-10, Otobashi Nakagawa-ku, Nagoya, Aichi 454-8509, Japan. zmorise@aol.com
Telephone: +81-52-3218171 Fax: +81-52-3234502
Received: January 25, 2015
Peer-review started: January 28, 2015
First decision: March 6, 2015
Revised: May 11, 2015
Accepted: June 1, 2015
Article in press: June 2, 2015
Published online: July 27, 2015
Processing time: 183 Days and 2 Hours
Peer-review started: January 28, 2015
First decision: March 6, 2015
Revised: May 11, 2015
Accepted: June 1, 2015
Article in press: June 2, 2015
Published online: July 27, 2015
Processing time: 183 Days and 2 Hours
Core Tip
Core tip: Liver resection (LR) for hepatocellular carcinoma patients with chronic liver disease has high risks for developing significant postoperative complications and multicentric metachronous lesions with need of repeated treatments. Laparoscopic LR has advantages of reduced surgery-induced parenchymal injury and destruction of the collateral blood/lymphatic flow, which leads to reduced production of postoperative ascites, and facilitates repeat LR because of reduced adhesion formation and improved vision/manipulation between adhesions. These characteristics of laparoscopic LR may lead to expansion of the indications for LR.